Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive therapy in patients with treatment failure or relapse of brucellosis
IRCT201407159855N7Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in brucellosis, sponsored by Arak University of Medical Sciences. Started Feb 2014; status: completed.
02
Drugs
arginine
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT201407159855N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201407159855N7.